At the request (and expense) of Kellogg’s, the Life Science Research Organization convened an expert panel to evaluate studies linking consumption of whole grains – as defined by FDA – to reduced risk of cardiovascular disease and diabetes. Using the FDA’s definition, the panel judged the studies insufficient to support a claim that whole grains reduce the risk of cardiovascular disease or diabetes. The FDA defines whole grains as whole: grains that are ground, cracked, or flaked but include all the parts in their original proportions. When the panel expanded the definition of whole grains to include supplements of bran, germ, or fiber, the results came out better. Supplements work better than the real thing! Kellogg’s must be pleased with the results of its investment.
Currently browsing posts about: Conflicts-of-interest
Oh no, not again! Merrill Goozner of the Integrity in Science project at Center for Science in the Public Interest (CSPI) writes that six of the 13 members of the 2010 Dietary Guidelines committee, including the chair, get research support or consulting fees from food or drug companies with vested interests in what the guidelines say. CSPI had to dig up this information, as the sponsoring agencies did not disclose these potential conflicts of interest.
The FDA’s lack of concern (see previous post) about the safety of bisphenol A has now come under criticism from a subcommittee of its own science advisory board. As described in USA Today, the board criticizes the FDA for relying too heavily on industry-funded studies and not holding the studies to rigorous scientific standards. Here’s the board’s report. An earlier story in the Milwaukee Journal Sentinal charged that the FDA used research – and a research summary – provided by the plastics industry as the basis of its original conclusion that bisphenol A posed no problems. It looks like this is turning out to be one of those unfortunate examples of industry interference with the risk assessment process. The science of food toxicology is difficult enough without this sort of thing happening. Alas.
I love the way sponsored science works. We now have data claiming that there is no difference in the quality of controlled clinical weight loss trials whether they are funded by industry or independently. The senior author on this comparative study is the very same person who was relieved of his responsibilities as head of a national obesity society because he wrote a letter opposing calorie labeling without disclosing that he was paid to do it (see previous post on this topic). NIH paid for this study in part (the other parts aren’t attributed). For this study, as the paper says, “Ethical approval is not required.”
Even I am astonished by this one. Greg Miller of the National Dairy Council sends me all the studies that favor eating dairy products. This one is a classic (of sorts) from the Journal of the American Dietetic Association . The study compares the nutrient value of conventional milk, rbGH-free milk, and organic milk and finds–surprise!–no significant difference. In case you need a reminder, rbGH is recombinant bovine growth hormone, the genetically engineered hormone that increases milk production in cows. Monsanto makes it. OK, class: it’s quiz time. The study has ten authors. Guess who seven of them work for (or used to work for)? Guess who paid for the study? And what are the other three authors doing there?
I’d been hearing rumors about how the the European Commission is spending $20 million to develop dietary recommendations and food standards that will apply to all EU member states. I now have some confirmation of them through the British magazine, Private Eye (May 30, 2008). The project, called EURRECA, will be conducted by a bunch of universities but the overall management is going to be through the European branch of the International Life Sciences Institute (ILSI), “a front for the food and bioscience industry.” ILSI is funded by Coca-Cola, McDonald’s, Bayer CropScience, and Monsanto, among other such entities. So $20 million in taxpayer dollars will be laundered through a food and agbiotech front group. Private Eye says that it eagerly awaits “EURRECA’s no doubt scientifically rigorous and untirely unbiased conclusions.”
I could do this for a lot less than $20 million, but nobody asked me, alas.
Ashley just posted this message: “Today I received an email from the American Dietetic Association [ADA] welcoming the Coca-Cola company as a corporate sponsor. As a rookie RD this type of announcement is perplexing and often disturbing. What is more bothersome is that the President of ADA referred to the American Public as consumers… How do I align myself with an organization that aligns themselves with industry more than social activism?
Thank you Ashley for reminding me about some previous comments about the ADA’s industry partnerships, including this one: “I feel badly that you chose to put down ADA for its message instead of joining forces and finding ways that we can work together…as an organization which does not have much money this is the way that we can fund educational programs for our members and get our scientific message out to the public…I hope that you will consider joining with us instead of voicing criticism for this well-respected organization of highly educated and well-trained health professionals.”
Respected ADA colleagues: as long as your organization partners with makers of food and beverage products, its opinions about diet and health will never be believed independent (translation: based on science not politics) and neither will yours. Consider the ADA’s Nutrition Fact Sheets, for example, each with its very own corporate sponsor (scroll down to the lower right hand corner of the second page to see who paid for the Facts). Is the goal of ADA really the same as the goal of the sponsors–to sell the sponsor’s food products? Is this a good way to get important scientific messages to the public? ADA members: how about doing something about this!
Today’s New York Times has a juicy article in the business section about the differing opinions of obesity experts about New York City’s proposal to require certain restaurants to post calorie information on menu boards. The head of one obesity society, who is a frequent consultant to the food and restaurant industry, apparently thinks calorie labeling will backfire by “inadvertently encouraging patrons to consume lower-calorie foods that subsequently lead to greater total caloric intake because of poor satiating efficiency of the smaller calorie loads.” Coincidence?